CymaBay Therapeutics Soars on Gilead Sciences Acquisition
CymaBay Therapeutics shares surged 25% and reached a new record high after the biopharmaceutical company agreed to be acquired...
clinical-stage
Disc Medicine Appoints New CFO and COO
In a strategic move, Disc Medicine has hired Jean Franchi as its new CFO and promoted Jonathan Yu to...
Kura Oncology Shares Surge on Oversubscribed Offering
Shares of Kura Oncology, a clinical-stage biotech company, surged 31% in premarket trading after a successful follow-on offering. The...
Harpoon Therapeutics Shares Soar on Merck Deal Talks
Shares of Harpoon Therapeutics have skyrocketed in premarket trading after reports emerged that the clinical-stage immunotherapy company is close...
Dyne Therapeutics Announces Stock Offering, Shares Slide 7.3%
Dyne Therapeutics, a clinical stage muscle disease company, has announced a public offering of $175 million of its common...
Fusion Pharma: Potential Merger Target in Radiopharmaceuticals
Fusion Pharmaceuticals Inc.'s stock is up 5.3% in premarket trading after analysts at Oppenheimer identified the company as a...
Theseus Pharmaceuticals Shares Rise 9.3% on Acquisition Deal
Shares of Theseus Pharmaceuticals surged after the company agreed to be acquired by Concentra Biosciences for $3.90 to $4.05...
AstraZeneca Acquires Icosavax for $1.1 Billion
In a move to bolster its vaccines and immune therapies pipeline, pharmaceutical giant AstraZeneca has announced its acquisition of...
AstraZeneca to Acquire Icosavax, Expanding Vaccine Pipeline
AstraZeneca, the pharmaceutical giant, has announced its plans to acquire Icosavax, a clinical-stage biopharmaceutical company, for up to $1.1...
Poseida Therapeutics Shares Surge on Positive Blood Cancer Treatment Data
Shares of Poseida Therapeutics surged 21% after the company announced positive early results from its phase 1 trial for...